Pallidotomy for Parkinson's disease: Hitting the target?

Lancet

Volumn 351, Issue 9108, 1998, Pages 998-999

  Golbe, L I ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVODOPA; NEUROLEPTIC AGENT;

HUMAN; PALLIDOTOMY; PARKINSON DISEASE; PRIORITY JOURNAL; SHORT SURVEY; STEREOTAXIC SURGERY;

EID: 0032481896     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)22014-9     Document Type: Note

References (7)

1. MS Baron JL Vitek RAE Bakay Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study Ann Neurol 40 1996 355 366
2. AE Lang AM Lozano E Montgomery J Duff R Tasker W Hutchinson Posteroventral medial pallidotomy in advanced Parkinson's disease N Engl J Med 337 1997 1036 1042
3. A Kishore IM Turnbull BJ Snow Efficacy, stability and predictors of outcome of pallidotomy for Parkinson's disease: six-month follow-up with additional 1-year observations Brain 120 1997 729 737
4. E Fazzini M Dogali D Sterio D Eidelberg A Beric Stereotactic pallidotomy for Parkinson's disease: a long-term follow-up of unilateral pallidotomy Neurology 48 1997 1273 1277
5. WG Ondo J Jankovic EC Lai Assessment of motor function after stereotactic pallidotomy Neurology 50 1998 266 270
6. KM Shannon RD Penn JS Kroin Stereotactic pallidotomy for the treatment of Parkinson's disease: efficacy and adverse effects at 6 months in 26 patients Neurology 50 1998 434 438
7. M Samuel E Caputo DJ Brooks A study of medical pallidotomy for Parkinson's disease: clinical outcome, MRI location and complications Brain 121 1998 59 75